Showing 1 - 20 results of 28 for search 'Alberto M. Borobia', query time: 0.06s Refine Results
  1. 1
    Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital

    Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital by Enrique S. Meseguer, Mikel U. Elizalde, Alberto M. Borobia, Elena Ramírez

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data

    Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data by Paloma Moraga Alapont, Paula Prieto, Mikel Urroz, María Jiménez, Antonio J. Carcas, Alberto M. Borobia

    Published 2023-12-01
    Get full text
    Article
  3. 3
    A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial

    A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the i... by Miguel Rodríguez-Rubio, Juan Carlos Figueira, Darío Acuña-Castroviejo, Alberto M. Borobia, Germaine Escames, Pedro de la Oliva

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance Program.

    Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance Program. by Raúl Muñoz, Alberto M Borobia, Manuel Quintana, Ana Martínez, Elena Ramírez, Mario Muñoz, Jesús Frías, Antonio J Carcas

    Published 2016-01-01
    Get full text
    Article
  5. 5
    Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals

    Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals by Ana Delgado, Stefan Stewart, Mikel Urroz, Amelia Rodríguez, Alberto M. Borobia, Ibtissam Akatbach-Bousaid, Miguel González-Muñoz, Elena Ramírez

    Published 2021-09-01
    Get full text
    Article
  6. 6
    Developments in pharmacogenetics, pharmacogenomics, and personalized medicine

    Developments in pharmacogenetics, pharmacogenomics, and personalized medicine by Francisco Abad-Santos, Salvador F. Aliño, Alberto M. Borobia, Elena García-Martín, Patricia Gassó, Olalla Maroñas, José A.G. Agúndez

    Published 2024-02-01
    Get full text
    Article
  7. 7
    An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease.

    An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease. by Alberto M Borobia, Rubin Lubomirov, Elena Ramírez, Alicia Lorenzo, Armando Campos, Raul Muñoz-Romo, Carmen Fernández-Capitán, Jesús Frías, Antonio J Carcas

    Published 2012-01-01
    Get full text
    Article
  8. 8
    Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity

    Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity by Stefan Stewart, Jose Manuel Dodero-Anillo, Javier Guijarro-Eguinoa, Pedro Arias, Arturo Gómez López De Las Huertas, Enrique Seco-Meseguer, Irene García-García, Elena Ramírez García, Elena Ramírez García, Carlos Rodríguez-Antolín, Antonio J. Carcas, Antonio J. Carcas, Sonia Rodriguez-Novoa, Rocio Rosas-Alonso, Rocio Rosas-Alonso, Alberto M. Borobia, Alberto M. Borobia

    Published 2023-10-01
    Get full text
    Article
  9. 9
    Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data

    Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Sp... by Elena Ramírez, Mikel Urroz, Amelia Rodríguez, Miguel González-Muñoz, Alberto Martín-Vega, Yuri Villán, Enrique Seco, Jaime Monserrat, Jesús Frías, Antonio J. Carcas, Alberto M. Borobia

    Published 2020-12-01
    Get full text
    Article
  10. 10
    Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial

    Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administr... by Ilaria Galgani, Airi Põder, Rain Jõgi, Veli-Jukka Anttila, Stefano Milleri, Alberto M. Borobia, Odile Launay, Marco Testa, Daniela Casula, Luca Grassano, Annaelisa Tasciotti, Marie Dozot, Ashwani K. Arora

    Published 2023-01-01
    Get full text
    Article
  11. 11
    Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates

    Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates by Miriam Saiz-Rodríguez, Susana Almenara, Marcos Navares-Gómez, Dolores Ochoa, Manuel Román, Pablo Zubiaur, Dora Koller, María Santos, Gina Mejía, Alberto M. Borobia, Cristina Rodríguez-Antona, Francisco Abad-Santos

    Published 2020-04-01
    Get full text
    Article
  12. 12
    Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriaceae

    Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriace... by Juan Carlos Ramos-Ramos, Fernando Lázaro-Perona, José Ramón Arribas, Julio García-Rodríguez, Jesús Mingorance, Guillermo Ruiz-Carrascoso, Alberto M. Borobia, José Ramón Paño-Pardo, Rafael Herruzo, Francisco Arnalich

    Published 2020-04-01
    Get full text
    Article
  13. 13
    Acute Poisoning Readmissions to an Emergency Department of a Tertiary Hospital: Evaluation through an Active Toxicovigilance Program

    Acute Poisoning Readmissions to an Emergency Department of a Tertiary Hospital: Evaluation through an Active Toxicovigilance Program by Raúl Muñoz Romo, Alberto M. Borobia Pérez, Rosa Mayayo Alvira, Mikel Urroz, Amelia Rodríguez Mariblanca, Francisco J. Guijarro Eguinoa, Lucia Diaz García, Julio Cobo Mora, Angelica Rivera, Rosario Torres, Antonio J. Carcas Sansuán

    Published 2022-08-01
    Get full text
    Article
  14. 14
    Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units

    Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units by Paloma Moraga, Paula Prieto, Almari Conradie, Majda Benhayoun, Vicki Rousell, Maria Davy, Uwe Fuhr, Rosa Antonijoan Arbos, Francisco Abad‐Santos, Antonio Portolés, Jolanda Van Duinen, Antonio J. Carcas, Alberto M. Borobia, the ERA4TB Consortium

    Published 2023-12-01
    Get full text
    Article
  15. 15
    Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial

    Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Cente... by Elena de Celis-Ruiz, Blanca Fuentes, María Alonso de Leciñana, María Gutiérrez-Fernández, Alberto M. Borobia, Raquel Gutiérrez-Zúñiga, Gerardo Ruiz-Ares, Laura Otero-Ortega, Fernando Laso-García, Mari Carmen Gómez-de Frutos, Exuperio Díez-Tejedor

    Published 2022-03-01
    Get full text
    Article
  16. 16
    Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation

    Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Tr... by Irene García-García, Irene Dapía, Jaime Montserrat, Lucía Martinez de Soto, David Bueno, Lucía Díaz, Javier Queiruga, Amelia Rodriguez Mariblanca, Pilar Guerra-García, Elena Ramirez, Jesus Frías, Antonio Pérez Martínez, Antonio J. Carcas-Sansuan, Alberto M. Borobia

    Published 2021-10-01
    Get full text
    Article
  17. 17
    Zika Virus Screening among Spanish Team Members After 2016 Rio de Janeiro, Brazil, Olympic Games

    Zika Virus Screening among Spanish Team Members After 2016 Rio de Janeiro, Brazil, Olympic Games by Natalia Rodriguez-Valero, Alberto M. Borobia, Mar Lago, Maria Paz Sánchez-Seco, Fernando de Ory, Ana Vázquez, Jose Luis Pérez-Arellano, Cristina Carranza Rodríguez, Miguel J. Martínez, Alicia Capón, Elias Cañas, Joaquin Salas-Coronas, Arkaitz Azcune Galparsoro, Jose Muñoz

    Published 2017-08-01
    Get full text
    Article
  18. 18
    A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.

    A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population. by Hoi Y Tong, Cristina Lucía Dávila-Fajardo, Alberto M Borobia, Luis Javier Martínez-González, Rubin Lubomirov, Laura María Perea León, María J Blanco Bañares, Xando Díaz-Villamarín, Carmen Fernández-Capitán, José Cabeza Barrera, Antonio J Carcas, PGX-ACE Investigators Group

    Published 2016-01-01
    Get full text
    Article
  19. 19
    Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19

    Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19 by Carlos Carpio, Ana Qasem, Antonio Buño, Alberto M. Borobia, Francisco Arnalich, Vega Rey, Teresa Lázaro, Pablo Mariscal, Daniel Laorden, Giorgina Salgueiro, Alberto Moreno, Concepción Peiró, Óscar Lorenzo, Rodolfo Álvarez-Sala, on behalf of COVID@HULP Working Group, on behalf of POSTCOVID@HULP Working Group

    Published 2023-09-01
    Get full text
    Article
  20. 20
    A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial

    A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary... by Irene García García, Miguel Rodriguez-Rubio, Amelia Rodríguez Mariblanca, Lucía Martínez de Soto, Lucía Díaz García, Jaime Monserrat Villatoro, Javier Queiruga Parada, Enrique Seco Meseguer, María J. Rosales, Juan González, José R. Arribas, Antonio J. Carcas, Pedro de la Oliva, Alberto M. Borobia

    Published 2020-06-01
    Get full text
    Article

Search Tools: